CXCL8 is increased in individuals with ARDS and is believed to contribute to ARDS pathology via neutrophil recruitment, inhibiting neutrophil apoptosis and activating lung endothelium (Chollet-Martin et al., 1993; Allen and Kurdowska, 2014). This evidence concerns the gene CXCL8 and acute respiratory distress syndrome.